State Street’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$179M Sell
2,647,054
-349,641
-12% -$19.8M 0.01% 1001
2025
Q4
$124M Buy
2,996,695
+950,028
+46% +$39.3M ﹤0.01% 1233
2025
Q3
$82.4M Sell
2,046,667
-119,086
-5% -$3.46M ﹤0.01% 1444
2025
Q2
$56.3M Buy
2,165,753
+198,264
+10% +$4.78M ﹤0.01% 1616
2025
Q1
$48.2M Buy
1,967,489
+43,905
+2% +$1.24M ﹤0.01% 1666
2024
Q4
$55.2M Buy
1,923,584
+222,931
+13% +$7.63M ﹤0.01% 1667
2024
Q3
$64.2M Buy
1,700,653
+717,722
+73% +$25.2M ﹤0.01% 1575
2024
Q2
$31M Buy
982,931
+632,100
+180% +$21.9M ﹤0.01% 1908
2024
Q1
$15.4M Buy
+350,831
New +$14.3M ﹤0.01% 2326

Other funds holding CGON